Manu Ohri

Insider Reports History

Entity
Individual
Location
2355 Main Street, Suite 120, Irvine, CA
Signature
/s/ Manu Ohri
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Manu Ohri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GT Biopharma, Inc. CFO & Secretary Common Stock 300K $86.1K $0.29 Aug 11, 2023 By Anarjay Concepts, Inc.
GT Biopharma, Inc. CFO & Secretary Common Stock 50K $14.4K $0.29 Aug 11, 2023 By Ohri Family Revocable Trust U/A Dated 02/10/2020
Axil Brands, Inc. Director Common Stock 10K $1.2K $0.12 Feb 14, 2024 By Anarjay Concepts Inc.
Axil Brands, Inc. Director Common Stock 5K $600 $0.12 Feb 14, 2024 Direct
GT Biopharma, Inc. CFO & Secretary Option to purchase Common Stock 500K Jan 27, 2023 Direct
GT Biopharma, Inc. CFO & Secretary Common Stock 0 $0.29 Aug 11, 2023 Direct

Insider Reports Filed by Manu Ohri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXIL Axil Brands, Inc. Feb 14, 2024 1 $0 4 Feb 20, 2024 Director
AXIL Axil Brands, Inc. Feb 14, 2024 0 $0 3 Feb 20, 2024 Director
GTBP GT Biopharma, Inc. Aug 11, 2023 3 $57.4K 4 Aug 15, 2023 CFO & Secretary
GTBP GT Biopharma, Inc. Apr 6, 2023 1 $25K 4 Apr 10, 2023 CFO & Secretary
GTBP GT Biopharma, Inc. Jan 27, 2023 1 $0 4 Feb 1, 2023 Chief Financial Officer
GTBP GT Biopharma, Inc. Jul 15, 2022 4 $0 4 Jul 19, 2022 CFO & Secretary
GTBP GT Biopharma, Inc. Feb 14, 2022 0 $0 3 Feb 18, 2022 Chief Financial Officer